MarketPeel
Insider Trading Intelligence
RA

Ramtin Agah

RNXT
CHIEF MEDICAL OFFICER · RENOVORX, INC. · CIK 0001862617
FILING MIX · LIFETIME86%/14%
BUYS
25
SELLS
4
TOTAL VALUE
$171.1K
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
621,727
AVG SELL PX
TRADE KIND
SHOWING 29 / 29
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 20 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ramtin Agah, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+84.62%+10.72%+0.15%+10.57%+7.48%
14d13+76.92%+12.27%+0.80%+11.47%+14.17%
30d13+84.62%+14.73%+3.66%+11.07%+10.76%
60d13+92.31%+26.13%+4.87%+21.26%+15.60%
90d13+76.92%+25.68%+5.26%+20.43%+24.06%
180d13(1 pending)+66.67%+15.56%+15.38%+2.41%-0.80%
1y13(7 pending)+83.33%+7.10%+24.93%-17.83%-11.48%
2y13(12 pending)+0.00%-46.15%+32.68%-78.83%-78.83%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RNXT · 621,727 shares · as of Apr 3, 2026
0278,365556,730835,0951,113,46020222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 25 buys / 4 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
621,727621,727Apr 3, 2026Apr 7, 2026View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
10,000$1.00$10.0K798,460Jan 21, 2026Jan 22, 2026View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
9,795$0.86$8.4K788,460Dec 31, 2025Jan 5, 2026View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
205$0.83$169778,665Dec 30, 2025Jan 2, 2026View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
12,000$0.85$10.2K778,460Dec 16, 2025Dec 17, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
10,000$0.96$9.6K766,460Dec 5, 2025Dec 8, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
12,000$0.80$9.6K756,460Nov 24, 2025Nov 24, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
10,000$0.80$8.0K744,460Nov 21, 2025Nov 24, 2025View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
63,63663,636Jul 1, 2025Jul 3, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
21,000$1.40$29.4K734,460Jun 5, 2025Jun 9, 2025View →
RNXT
RENOVORX, INC.
SALEGRANT
Gift
400,000713,460Apr 22, 2025Jun 6, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
15,000$0.90$13.5K1,113,460Apr 15, 2025Apr 17, 2025View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
254,542254,542Apr 14, 2025Apr 16, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
20,000$0.80$16.0K1,098,460Apr 11, 2025Apr 14, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
30,000$0.81$24.4K1,078,460Apr 9, 2025Apr 10, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
26,000$0.84$21.8K1,048,460Apr 8, 2025Apr 9, 2025View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
40,98340,983Jan 26, 2024Jan 30, 2024View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
40,98347,460Jan 26, 2024Jan 30, 2024View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
28,42428,424Jan 19, 2024Jan 23, 2024View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
125,132125,132Jan 19, 2024Jan 23, 2024View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
65,00065,000Mar 15, 2023Mar 29, 2023View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
5,182$1.93$10.0K6,477Jun 7, 2022Jun 8, 2022View →
RNXT
RENOVORX, INC.
SALEGRANT
Gift
975,0001,295Mar 16, 2022Jun 8, 2022View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Gift
975,000975,000Mar 16, 2022Jun 8, 2022View →
RNXT
RENOVORX, INC.
SALEGRANT
Stock grant
21,39821,398Mar 10, 2022Mar 11, 2022View →
RNXT
RENOVORX, INC.
PURCHASEGRANT
Stock grant
52,20352,203Sep 30, 2021Oct 4, 2021View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
1,2951,295Aug 30, 2021Jun 17, 2022View →
RNXT
RENOVORX, INC.
SALE
Chief Medical Officer
1,2950Aug 30, 2021Jun 17, 2022View →
RNXT
RENOVORX, INC.
PURCHASE
Chief Medical Officer
1,295976,295Aug 30, 2021Jun 17, 2022View →
Other insiders · RNXT
Loading peer insiders…
About this filer
CIK 0001862617
ROLE
Chief Medical Officer
PRIMARY
RNXT
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001862617DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback